![](/img/cover-not-exists.png)
Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years
Mickaël Hiligsmann, Olivier Bruyère, Jean-Yves ReginsterVolume:
46
Year:
2010
Language:
english
Pages:
447
DOI:
10.1016/j.bone.2009.08.052
File:
PDF, 318 KB
english, 2010